Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Dyadic International Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
DYAI
Nasdaq
8731
https://dyadic.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Dyadic International Inc
Dyadic International, Inc. (NASDAQ:DYAI) Q4 2023 Earnings Call Transcript
- Apr 1st, 2024 4:24 pm
DYAI: Capital Raise to Accelerate Near Term Revenue Growth
- Apr 1st, 2024 12:58 pm
Q4 2023 Dyadic International Inc Earnings Call
- Mar 29th, 2024 11:18 am
Dyadic Reports 2023 Full Year Results and Recent Company Progress
- Mar 28th, 2024 8:00 pm
Dyadic Announces Change in Board and Management Leadership Roles
- Mar 28th, 2024 12:30 pm
Dyadic to Attend Industry Events in April
- Mar 27th, 2024 12:30 pm
Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications
- Mar 26th, 2024 12:30 pm
Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, California
- Mar 21st, 2024 12:30 pm
Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024
- Mar 14th, 2024 8:30 pm
CORRECTION – Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization
- Mar 11th, 2024 1:57 pm
Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization
- Mar 11th, 2024 12:30 pm
Dyadic to Attend Industry Events in March
- Mar 1st, 2024 1:30 pm
Dyadic Announces Strategic Partnership Agreement to Develop Affordable Rabies Prophylactics and Vaccines Using its Proprietary C1 Cell Microbial Protein Production Platform
- Feb 28th, 2024 1:30 pm
Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions
- Feb 23rd, 2024 7:00 am
DYAI: Catching Up With Dyadic
- Feb 20th, 2024 9:58 am
Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing
- Feb 13th, 2024 1:30 pm
Dyadic Announces Research and Development Collaboration Agreement with Global Biopharmaceutical Company
- Feb 6th, 2024 1:30 pm
Dyadic to Attend BIO CEO & Investor Conference and European Industry Events
- Feb 1st, 2024 1:30 pm
Dyadic International, Inc Invites You to Join Us at The Microcap Conference
- Jan 22nd, 2024 1:00 pm
Dyadic to Attend J.P. Morgan 42nd Annual Healthcare Conference
- Jan 2nd, 2024 1:30 pm
Scroll